Grape King Bio reports Aug revenue of NT$706.1M vs NT$884.1M
Grape King Bio Ltd. reported 2026 revenue of NT$706,058,000 versus NT$884,118,000 in 2025. For Jan-Aug, revenue was NT$6,114,390,000 versus NT$6,460,456,000 in the prior year, per Taiwan Stock Exchange data.
Grape King Bio Ltd. reported 2026 revenue of NT$706,058,000 versus NT$884,118,000 in 2025. The company also said Jan-Aug revenue was NT$6,114,390,000, compared with NT$6,460,456,000 a year earlier. Figures are in New Taiwan dollars and were sourced from the Taiwan Stock Exchange.